VEGF-Mediated STAT3 Activation Inhibits Retinal Vascularization by Down-Regulating Local Erythropoietin Expression
Open Access
- 31 March 2012
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 180 (3), 1243-1253
- https://doi.org/10.1016/j.ajpath.2011.11.031
Abstract
No abstract availableKeywords
Funding Information
- NIH (R01 R01EY015130, R01EY017011)
- March of Dimes (MOD 6-FY08-590)
This publication has 54 references indexed in Scilit:
- Organogenesis and tumorigenesis: Insight from the JAK/STAT pathway in the Drosophila eyeDevelopmental Dynamics, 2010
- Reduction in endothelial tip cell filopodia corresponds to reduced intravitreous but not intraretinal vascularization in a model of ROPExperimental Eye Research, 2009
- The Role of Supplemental Oxygen and JAK/STAT Signaling in Intravitreous Neovascularization in a ROP Rat ModelInvestigative Ophthalmology & Visual Science, 2009
- Prolyl hydroxylase inhibition during hyperoxia prevents oxygen-induced retinopathyProceedings of the National Academy of Sciences of the United States of America, 2008
- Activated NAD(P)H Oxidase from Supplemental Oxygen Induces Neovascularization Independent of VEGF in Retinopathy of Prematurity ModelInvestigative Ophthalmology & Visual Science, 2008
- IGF binding protein-3 regulates hematopoietic stem cell and endothelial precursor cell function during vascular developmentProceedings of the National Academy of Sciences of the United States of America, 2007
- IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowthProceedings of the National Academy of Sciences of the United States of America, 2007
- Triamcinolone Reduces Neovascularization, Capillary Density and IGF-1 Receptor Phosphorylation in a Model of Oxygen-Induced RetinopathyInvestigative Ophthalmology & Visual Science, 2006
- The Early Treatment for Retinopathy Of Prematurity Study: structural findings at age 2 yearsBritish Journal of Ophthalmology, 2006
- Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitorNature, 1996